CDKL5 DEFICIENCY DISORDER

Clinical trials for CDKL5 DEFICIENCY DISORDER explained in plain language.

Never miss a new study

Get alerted when new CDKL5 DEFICIENCY DISORDER trials appear

Sign up with your email to follow new studies for CDKL5 DEFICIENCY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Hope for infants: new drug trial targets devastating seizures in rare genetic disorder

Disease control Not yet recruiting

This study is testing whether adding a new medicine called ganaxolone to a child's current seizure medications can better control seizures in infants with a rare genetic disorder called CDKL5 deficiency. It will involve about 20 infants aged 6 months to under 2 years old. For 12 …

Matched conditions: CDKL5 DEFICIENCY DISORDER

Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

CDKL5 DEFICIENCY DISORDER

Get alerted when new CDKL5 DEFICIENCY DISORDER trials appear

Hope for infants: new drug trial targets devastating seizures in rare genetic disorder